iQuantitator: A tool for protein expression inference using iTRAQ by Schwacke, John H et al.
BioMed  Central
Page 1 of 15
(page number not for citation purposes)
BMC Bioinformatics
Open Access Software
iQuantitator: A tool for protein expression inference using iTRAQ
John H Schwacke*1, Elizabeth G Hill2, Edward L Krug3, Susana Comte-
Walters4 and Kevin L Schey5
Address: 1Department of Biochemistry, Medical University of South Carolina, Charleston, South Carolina, USA, 2Department of Medicine, Medical 
University of South Carolina, Charleston, South Carolina, USA, 3Department of Cell Biology and Anatomy, Medical University of South Carolina, 
Charleston, South Carolina, USA, 4Department of Pharmacology, Medical University of South Carolina, Charleston, South Carolina, USA and 
5Mass Spectrometry Research Center, Vanderbilt University, Nashville, Tennessee, USA
Email: John H Schwacke* - schwacke@musc.edu; Elizabeth G Hill - hille@musc.edu; Edward L Krug - krugel@musc.edu; Susana Comte-
Walters - comtewal@musc.edu; Kevin L Schey - k.schey@vanderbilt.edu
* Corresponding author    
Abstract
Background:  Isobaric Tags for Relative and Absolute Quantitation (iTRAQ™) [Applied
Biosystems] have seen increased application in differential protein expression analysis. To facilitate
the growing need to analyze iTRAQ data, especially for cases involving multiple iTRAQ
experiments, we have developed a modeling approach, statistical methods, and tools for estimating
the relative changes in protein expression under various treatments and experimental conditions.
Results:  This modeling approach provides a unified analysis of data from multiple iTRAQ
experiments and links the observed quantity (reporter ion peak area) to the experiment design and
the calculated quantity of interest (treatment-dependent protein and peptide fold change) through
an additive model under log transformation. Others have demonstrated, through a case study, this
modeling approach and noted the computational challenges of parameter inference in the
unbalanced data set typical of multiple iTRAQ experiments. Here we present the development of
an inference approach, based on hierarchical regression with batching of regression coefficients and
Markov Chain Monte Carlo (MCMC) methods that overcomes some of these challenges. In
addition to our discussion of the underlying method, we also present our implementation of the
software, simulation results, experimental results, and sample output from the resulting analysis
report.
Conclusion: iQuantitator's process-based modeling approach overcomes limitations in current
methods and allows for application in a variety of experimental designs. Additionally, hypertext-
linked documents produced by the tool aid in the interpretation and exploration of results.
Background
Recent advances in instrumentation, reagents, and tech-
niques for high throughput proteomics are making it pos-
sible to simultaneously identify and compare disease,
development, and treatment-related changes to the level
of protein expression [1]. In most cases, these techniques
rely on two dimensional gel electrophoresis (2DGE) or
liquid chromatography (LC) to separate proteins or pep-
tides by charge, mass, or other chemical properties fol-
lowed by identification using mass spectrometry (MS).
Published: 18 October 2009
BMC Bioinformatics 2009, 10:342 doi:10.1186/1471-2105-10-342
Received: 23 June 2009
Accepted: 18 October 2009
This article is available from: http://www.biomedcentral.com/1471-2105/10/342
© 2009 Schwacke et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Bioinformatics 2009, 10:342 http://www.biomedcentral.com/1471-2105/10/342
Page 2 of 15
(page number not for citation purposes)
For gel-based techniques, quantitation is performed by
comparing the intensity of associated spots in gel images
or by comparing the intensity of signals from appropri-
ately excited Cyanine reactive dyes used to tag the samples
being compared [2]. For techniques using liquid chroma-
tography, methods for quantitating expression can be
grouped into two broad classes: differential labeling, and
label-free LC-MS [3]. Labeling methods such as SILAC,
ICAT, and iTRAQ use isotopic or isobaric tags to differen-
tially label the samples being compared and paired
reporter ion or isotopic peaks provide estimates of the
expression ratio for identified peptides. Label free meth-
ods estimate peptide abundance from a chromatographic
elution profile, integrated across retention time or from
the frequency with which a peptide is selected from an MS
scan for MSMS analysis, termed spectral counting. In the
former case, the integrated profile is taken to be indicative
of the abundance of the associated peptide and thus a
measure of associated protein abundance. In spectral
counting, the methods compute protein abundance indi-
ces from the average of the associated peptide abundances
based on these frequencies.
The isobaric Tag for Relative and Absolute Quantitation
(iTRAQ™), has seen increased application in quantitative
proteomics [4]. This technique uses four (or eight [5]) iso-
baric reagents to label and compare four (or eight) protein
samples simultaneously. These reagents incorporate
chemical tags consisting of a reporter group, a balance
group, and a reactive group. The reactive group attaches
the tag to free primary amino groups (e.g. N-terminal
amines and lysines) where reporter groups, with masses of
114, 115, 116, and 117 Daltons, are linked to the reactive
group by complementary balance groups with masses of
31, 30, 29, and 28 Daltons. The compensating masses of
the reporter and balance groups yield a common mass of
145 Daltons. Therefore, a given peptide, modified by any
of the individual iTRAQ reagents, appears at the same
mass to charge in the MS spectrum. However, tandem MS
spectra of these peptides yield, in addition to the identify-
ing fragment ion peaks, reporter ion peaks at m/z 114,
115, 116, and 117 resulting from the singly charged
reporter groups. The relative intensities of the reporter ion
peaks are indicative of the relative quantities of the associ-
ated peptide across the four samples, from which relative
expression of the cognate protein is inferred.
Each iTRAQ experiment produces tens of thousands of
spectra (several gigabytes of data), several thousand iden-
tified peptides, and hundreds of identified proteins. Bio-
informatic tools and statistical methods are essential to
the interpretation of these data. Several data management
and analysis tools have been developed to analyze these
data, such as ProQuant, and ProteinPilot, software sup-
plied by the manufacturer of the iTRAQ reagents, and a
number of freely available tools. The software packages i-
Tracker [6] and TandTRAQ [7] support the analysis of
iTRAQ-generated quantitation data and the integration of
that analysis with search results from Mascot, Sequest, and
X!Tandem. The i-Tracker software performs reporter ion
peak area calculations, isotopic impurity correction,
threshold checking, and spectrum-level expression ratio
calculations and links quantitations to peptide identities
provided by Sequest or Mascot. TandTRAQ additionally
provides a method for combining spectrum-level quanti-
tation data from i-Tracker with peptide identifications
from X!Tandem. Another iTRAQ data analysis tool, Multi-
Q, provides instrument-independent processing, extracts
reporter ion peak intensities, eliminates redundant pep-
tides, and compensates for reporter ion saturation and
variations in spectrum quality [8,9]. Multi-Q additionally
provides both graphical- and web-based user interfaces.
Quant, a MATLAB-based software package for iTRAQ data
analysis, provides protein-level relative expression esti-
mates and associated uncertainty measures using error
propagation techniques [10]. Data management tools
such as the Yale Protein Expression Database (YPED)
facilitate biological interpretation through the capture,
display, and linking of data from proteomic experiments
using a variety of experimental techniques including
iTRAQ [11]. Extensions to the Proteomics Identifications
Database (PRIDE) and mzData standards have been pro-
posed to permit the storage of iTRAQ reporter ion intensi-
ties [12,13]. Tools such as these for data manipulation,
analysis, and storage are essential to the application of
iTRAQ.
While early iTRAQ-based studies focused on comparisons
to a common reference, a variety of experimental designs
have now been suggested [14] and will likely grow in
response to the introduction of higher throughput meth-
ods (e.g., 8-plex iTRAQ). In addition to increased com-
plexity in experimental designs, pooling of information
across experiments is needed to increase the power to
detect small changes in expression and to improve esti-
mates of the magnitude of those changes. Accommodat-
ing these advances will require statistical methods that
support a variety of designs and permit inference across
multiple iTRAQ experiments. Recently, we proposed a
model for iTRAQ data analysis based on Analysis of Vari-
ance (ANOVA) [15]. The approach yields a linear model
in log intensities from an iTRAQ experiment that can be
analyzed using ANOVA methods. Oberg and colleagues
apply this model in a study consisting of 6 iTRAQ experi-
ments and discuss the computational challenges associ-
ated with fitting thousands of model parameters in the
context of missing data typical of iTRAQ [14]. They
emphasize the superiority of methods capable of simulta-
neously fitting all of the parameters to all of the data,
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discuss strategies for dealing with these computational
issues including subsetting, stagewise, and iterative regres-
sion. In the software described here, we attempt to address
some of these difficulties using computational methods
from the Bayesian statistical framework.
We report on the development and application of a new
software tool, iQuantitator, designed to facilitate the anal-
ysis and reporting of results from iTRAQ experiments.
This tool employs a model-based approach to describe
sources of variation in the observed data and Bayesian
inference to estimate the parameters of interest and their
uncertainty, supports inference across multiple iTRAQ
experiments addressing a common hypothesis, allows
both protein and peptide-level treatment-effect analysis,
and produces a hypertext-linked and searchable electronic
report in the Portable Document Format (pdf).
Implementation
Reporter Ion Intensity Model
In the software described here, statistical inference
employs a model that links experimental observations to
the technical and experimental sources of variation and
provides the basis for the inference of treatment-depend-
ent changes in protein and peptide expression. We adapt
our recently reported model for the analysis of iTRAQ data
[15] in which the effects of the model are derived from the
steps of the experimental process. The model is given by a
multiplicative expression relating reporter ion peak area
to biological and experimental factors associated with that
peak. Log transformation of this multiplicative expression
yields the following expression where the log reporter ion
intensity is written as a linear combination of factors that
decompose the sources of variation in the observed log
reporter peak area (see Figure 1 for a definition of the
terms).
This approach provides a framework for constructing
models. For each study, the model must be tailored to
capture the pertinent sources of variation and experimen-
tal effects of interest. In our previous efforts and those of
log ,, , , ( ) , , , , Ip r f g v b s iji cqtq l ii c ji ji c ql q tq () () () ( () =+ + + + ++ ) )( ) ( ) ++ hk iji cqtq l ,, , ,,
(1)
Each source of variation included in the model is represented by a batch of parameters (see [15]) Figure 1
Each source of variation included in the model is represented by a batch of parameters (see [15]). The batches, 
prior distributions and associated hyperpriors are given here. Parameters are indexed as follows: protein: i, peptide: j(i), treat-
ment: c, experiment: q, tag (or channel): l, spectrum: t(q). For the normal distribution x ~ N(, ), the form of the density is 
 and for the gamma distribution  ~ G(, m), the form of the density is  .
Batch Model 
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Oberg, this model was analyzed using ANOVA, where the
parameters are structured into batches that explain the
sources of variation in the observed reporter ion peak
area. All of the parameters associated with an effect of the
model, for example protein effects (pi), are considered as
a batch. While it is important to understand which sources
of variation explain the observations, we are primarily
interested in the inferred values of those effects that
include an interaction with treatment, specifically, the
protein by treatment interaction effect (ri, c). It is these
parameter values that indicate treatment-dependent
changes in protein expression. In Equation (1), we note
that peptides are considered to be uniquely assigned to a
protein as indicated by the notation j(i), indicating that
peptide  j  is always associated with protein i. In cases
where a peptide could be assigned to more than one pro-
tein, it is eliminated from consideration prior to analysis.
Examination of the model reveals the computational chal-
lenges discussed by Oberg and colleagues [14]. The model
includes a number of parameters approximately equal to
(Ntreatment -1) × (Nprotein +  Npeptide) and these parameters
must be estimated from the Nspectra × Nchannel reporter ion
intensities. In addition to the large number of parameters
and the resulting computational costs, the inference
method must contend with missing data. Within an
experiment, many proteins are identified by a single pep-
tide and the peptide and protein effects for that protein
cannot, using traditional ANOVA techniques, be esti-
mated independently. Additionally, the limited overlap in
proteins identified in replicate iTRAQ experiments results
in proteins that may not be observed in all experiments.
In the experiments reported by Oberg [14], nearly 75% of
the 992 identified proteins appeared in only one of six
iTRAQ experiments and Liu, et. al [16] reported that 24%
of 1751 identified proteins appeared in only one of nine
iTRAQ experiments. To overcome these difficulties we
employ a statistical model that allows information shar-
ing across levels of a given effect and employ Markov
Chain Monte Carlo methods to infer parameters from the
data and parameter prior distributions.
Model Parameter Inference
Parameter inference in iQuantitator employs computa-
tional methods developed using the Bayesian statistical
framework. Applying Bayes theorem, the probability den-
sity of the model parameters conditioned on the observed
data can be written as the product of the likelihood, the
prior densities of the parameters, and integration con-
stant. The joint posterior density of the parameters is
obtained by integrating the likelihood over the prior den-
sities. When a closed form solution of this integral is una-
vailable, computational methods such as Markov Chain
Monte Carlo (MCMC) can be used [17]. The Markov
chain constructed using these methods yields samples dis-
tributed according to the posterior distribution of the
parameter vector. Statistical measures of center and spread
estimated from these samples can be used to characterize
the parameters of interest. Applying these methods to
iTRAQ data requires the construction of a statistical model
describing the prior distributions for each model parame-
ter and, potentially, hyperprior distributions for distribu-
tional parameters of those priors. The statistical model
structure used here follows the recommendation of Gel-
man [18] for the analysis of ANOVA using hierarchical
regression. In this approach, all parameters of a given
effect are considered as a batch and share a common prior
distribution. Distributional assumptions of this model are
given in Figure 1.
The Gibbs sampler implemented in iQuantitator was
designed to exploit the structure of the model. Let xi be the
ith observed reporter ion peak area, assumed distributed
where aw are parameters of the model and Si are the set of
parameter indices associated with peak area i. In our case,
the set Si gives the indices of the parameters, one from
each batch, that sum to give the mean of the distribution
of xi and aw  {p|r|f|g|v|b|s|h}. The prior distributions for
the aw are given by
where  B(w) gives the batch to which parameter w  is
assigned (see Figure 1 for the prior specifications for each
batch of parameters). Under these assumptions we can
write closed form expressions for the full conditional dis-
tributions for parameters and hyperparameters of the
model. For each parameter aw the full conditional distri-
bution is given by
where Dw is the set of indices of observed reporter ion
peaks whose mean depends on aw  and  n() gives the
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number of members of the set. The hyperparameters for
the prior distribution of batch b are updated using
where Hb gives the set of indices of parameters assigned to
batch b. Finally, the model precision parameter is updated
using
Within a batch, the update of a parameter depends only
on the observed reporter ion peak areas assigned to the
associated factor level. Since each observation is assigned
to only one parameter within a batch, during each itera-
tion of the algorithm, all parameters assigned to a given
batch are updated in parallel. For each batch, the software
computes all of the sums in Equation (2) in one pass
through the data, forming partial sums as needed. Once
completed, all parameters in the batch are updated fol-
lowed by updates to the batch hyperprior parameters b
and b and this process is repeated for each batch. Finally,
the model precision is updated. Throughout the batch
updates, the means (i) are updated so that computa-
tional effort in the precision update is reduced.
Software Description
iQuantitator is available as an installable package for the
freely-available R statistical computing environment and,
through scripting, can be tailored to a variety of iTRAQ
study designs. The package includes a collection of R func-
tions for structuring input files, a Gibbs sampler designed
for this application, and an R/latex script used to construct
hypertext-linked reports. To make use of the package,
users create an R script that specifies the input files,
defines the experiment, gives the statistical model and the
comparison of interest, and specifies the results file
names. The software is intended for use by statisticians

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The iQuantitor processing flow is divided into 3 main steps, data filtering, parameter inference, and report generation Figure 2
The iQuantitor processing flow is divided into 3 main steps, data filtering, parameter inference, and report 
generation. Each step corresponds to an R function as described in the text. The processing sequence can be customized to 
include additional analyses or diagnostics.
Data Filtering
Parameter Inference
Report Generation
Formatting
Experiment Design,
Filtering Criteria
Statistical Model, Prior
Distributions, Inference
Parameters
Title, Project Name,
Report Template, etc.
AA Sequence
Database (FASTA)
Reporter Ion Peak Areas,
Experiment, Peptide, Protein,
Fraction, etc.
R Statistical Package
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and analysts familiar with experimental design and statis-
tical modeling. The processing flow of a typical iQuantita-
tor application is illustrated in Figure 2
Data Import and Filtering
For each study, the user specifies the study design indicat-
ing the treatment group and sample identifier for each
channel within each iTRAQ experiment (Figure 2). For
each experiment, the user also provides a file giving the
MS/MS reporter ion measurements, and peptide and pro-
tein identities for each MS/MS spectrum. iQuantitator
relies on other external or vendor-supplied software to
identify proteins from peptide-level tandem mass spectra
(e.g. Mascot), measure iTRAQ reporter ion peak areas, and
correct the peak areas for isotopic impurities in the iTRAQ
reagents. The input file is typically a table containing one
line for each observed MS/MS spectrum giving the name
and accession number of the associated protein, spot or
fraction identifier, best peptide sequence, list of modifica-
tions, and the reporter ion peak areas for each of the
iTRAQ tags. These data are typical of that provided in the
MS/MS summary reports generated by the Applied Biosys-
tems software and is converted to a tab-delimited text file
prior to processing. The default column names for each of
these data items can be customized to match the tables
produced by specific instruments and associated software.
Data import and filtering is implemented in the loadMS
MSSummary function. In addition to the study design and
a list of associated MS/MS summary files, the user may
also specify contaminating proteins and protein modifica-
tions to be eliminated prior to analysis. The protein and
modification filters are specified as lists of regular expres-
sions [19], one expression for each protein or modifica-
tion to be eliminated from the analysis. During loading,
the protein name and modification fields in the MS/MS
summary files are checked against the list of filtered pro-
teins and modifications and are eliminated from the data
set prior to analysis. Most often, this feature is used to
eliminate experimental contaminants and peptides con-
taining iTRAQ-modified tyrosines. In our applications,
peptides without high confidence assignments (peptide
assignment confidence below 70%) are also eliminated
during the filtering step. The confidence threshold is spec-
ified using the confthreshold argument to loadMS
MSSummary, and a count of spectra below threshold is
provided in the summary report. Additionally, spectra
assigned to more than one protein, unidentified spectra,
and spectra with out-of-range data are also eliminated.
The remaining data is restructured as a table with one row
per reporter ion peak containing, in addition to the log
transformed peak area, the descriptors of that peak (exper-
iment, channel/tag, spectrum, protein, peptide, spot,
treatment group, and sample). Additionally the software
constructs a summary of the input data including: the
number of spectra, unique proteins and unique peptides;
the number of spectra eliminated during filtering or due
to missing data; and the number of spectra observed for
each reported peptide within each experiment.
Statistical Inference
To identify treatment-dependent, differentially expressed
proteins, iQuantitator employs Bayesian inference using
Gibbs Sampling as described above. This step is imple-
mented within the processiTRAQ function. The user
supplies a statistical model, specific to the experimental
design, relating log-transformed reporter ion peak areas to
the treatment effects of interest and other sources of vari-
ation. The user-supplied model, expressed in a restricted
version of the R formula grammar, is specified so as to
capture both the comparisons of interest and the sources
of variation that interfere with those comparisons. The
user may also specify parameters controlling the Gibbs
sampler and prior distributions for the model parameters.
The Gibbs sampler, implemented as a C library function,
is used to draw samples of the model parameter vector
from its joint posterior distribution. The sampling process
produces a large table, with one row per monitored
parameter (approximately twice the sum of the number of
unique peptides and unique proteins) and number of col-
umns equal to the number of samples retained (thou-
sands of columns). The user-specified thinning and burn-
in parameters control the number of MCMC iterations
between stored samples and the number of samples dis-
carded at the beginning of the sampling process, and can
be used to reduce this table to a reasonable size. Monitor-
ing flags for each factor allow data collection to be selec-
tively bypassed for nuisance parameters. To assess
convergence, MCMC variable trace plots can be generated
and MCMC diagnostics can be applied to the sampled
parameters using existing R packages [20] and functions.
Statistical Summary Preparation
For each parameter of interest, iQuantitator computes
summary statistics giving a point estimate and credible
interval from which the fold change estimate and its
uncertainty can be determined. This step is performed in
the summarizeiTRAQ function. Although the software
draws samples from the joint posterior distribution for all
of the parameters in the model, we focus our statistical
summary only on those parameters associated with the
treatment effects. In particular, we focus on the protein-
treatment interaction factor, and the peptide-treatment
interaction factor, typically specified in the model. For
each parameter within these effects, the software esti-
mates, using samples collected from the MCMC algo-
rithm, the mean, median, standard deviation, and 2.5th
and 97.5th percentiles. These values are exponentiated to
give both point estimates (mean and median) and credi-
ble intervals (2.5th and 97.5th percentiles) for the proteinBMC Bioinformatics 2009, 10:342 http://www.biomedcentral.com/1471-2105/10/342
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and peptide fold change due to treatment. The protein
and associated peptide summary statistics are organized
into a hierarchical data structure. Additionally, the soft-
ware builds a map of identified peptides along the associ-
ated protein sequence. The protein accession number is
used to locate the protein sequence in a user-supplied pro-
tein database file (in FASTA format). The sequence is then
included in the resulting data structure.
Report Preparation
The final step in the iQuantitator processing sequence is
the construction of a latex document (.tex file) containing
formatted versions of the experiment description, statisti-
cal model, data summary, and protein and peptide treat-
ment effect summary data structures. This step utilizes the
Sweave automatic report generator, a component of the R
utils package. Sweave processes a user-supplied script
containing both latex and R code and merges the output
of the R code with the latex to create a .tex file suitable for
document production. The resulting .tex file is then con-
verted into a Portable Document Format (.pdf) file using
the  pdflatex processor. The iQuantitator package
includes a default Sweave script that can be used as is or
modified to change the form, content, or organization of
the resulting report. The document is structured to pro-
vide both graphical and numerical summaries of the
results with hypertext links providing quick access to doc-
ument sections containing detailed analyses (see Figure
3). The protein summary section provides a graphical and
numeric summary of all identified proteins with results
sorted by decreasing magnitude of expression fold
change. Protein names are hypertext linked to subsections
within the Protein Details section where additional statis-
tics, protein sequences showing peptide coverage, and
peptide-level expression change summaries can be found.
The protein accession number, given in each subsection of
Protein Details, also provides a hypertext link to the NCBI
Protein database (Figure 4). Clicking on this link will
launch the user's web browser and direct it to the appro-
priate NCBI Protein web page on most platforms. Addi-
tionally, the summary report document can be navigated
using bookmarks and searched using the search tools
found in most Portable Document Format readers such as
Adobe's Acrobat Reader [21].
Software was developed using version 2.6.2 of the R Sta-
tistical Computing Environment [22].
Simulated Data Sets
A set of simulated data sets was produced to further inves-
tigate the performance of iQuantitator. Two sets of four
tests simulating studies with single iTRAQ runs and one
set of two iTRAQ experiments from a single study were
generated using a simulator developed in our laboratory
for testing inference methods. Biological, treatment, and
technical variation can be set as desired to construct sim-
ulated protein expression profiles for individual samples.
The simulator models the peptide composition of pro-
teins, inserts post-translational modifications and treat-
ment-dependent modifications, models loading errors,
labeling efficiency, fractionation of peptides, MS intensi-
ties, peak selection logic, and reporter ion measurement
noise. The resulting output is converted, via an R script,
into files satisfying the input requirements of iQuantita-
tor. For this study, the simulator was configured to draw
from a pool of 5000 proteins composed of peptides from
a pool of 850,000. The peptides were randomly assigned
modifications with a probability of 0.05. Both loading
error and tagging efficiency were set to model ideal condi-
tions and the peptides were distributed across 14 first
dimension fractions and 400 second dimension fractions.
Peak selection was limited to peptides in the m/z range
800 to 3500 and only the 10 most intense peaks in the
simulated mass spectrum were processed in simulated
MSMS. A peak was not reinterogated if already appearing
in any of the 30 previous fractions. The ion suppression
model was set as to minimize the effects of suppression
and treatment, biological and technical noise were added
to the output. Each simulation run modeled samples from
four subjects, two each from two treatment groups. Chan-
nels 1 and 3 were assigned to subjects from treatment
group 1 and channels 2 and 4 to subjects from treatment
The default report structure provides increasingly detailed  summaries of the results with in-document hypertext links  between single line protein summaries in Section 4 to sub- sections of Section 5 containing additional details for each  protein and a summary of the supporting evidence from each  peptide Figure 3
The default report structure provides increasingly 
detailed summaries of the results with in-document 
hypertext links between single line protein summa-
ries in Section 4 to subsections of Section 5 contain-
ing additional details for each protein and a summary 
of the supporting evidence from each peptide. Within 
these details, the document provides external links to the 
Proteins database at NCBI.BMC Bioinformatics 2009, 10:342 http://www.biomedcentral.com/1471-2105/10/342
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Sample pages of the analysis report for the biological sample discussed here show the form and content of the report Figure 4
Sample pages of the analysis report for the biological sample discussed here show the form and content of the 
report. The experiment design, statistical model, and a summary of the raw data are given on the first two pages followed by 
a summary (one line per protein) of data for proteins identified by more than one peptide (pages 2 and 3 of this example). Each 
protein summary provides a hypertext link to detailed information (page 17 in this example) found later in the document. 
Clicking on the protein accession number links to NCBI.BMC Bioinformatics 2009, 10:342 http://www.biomedcentral.com/1471-2105/10/342
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group 2. Each experiment dataset contained approxi-
mately 1050 unique proteins, 4800 unique peptides, and
7000 spectra (see Table 1). Four additional single-run
experiments of similar design were simulated, this time
including treatment-dependent modifications. When
treatment-dependent modifications are included and the
modified form of the protein is not observed, datasets
include peptides whose expression ratio differs signifi-
cantly from other peptides of the same protein. Finally,
one additional simulation dataset was constructed to
examine the analysis of data from multi-iTRAQ studies. In
this case, a common pooled control is included in the first
channel of two experiments and simulated samples from
six individuals of the treatment group are assigned to the
three channels remaining in each of the two experiments.
The simulated data set included 1321 proteins, 6762 pep-
tides, and 13,524 spectra. Of the 1321 proteins, 47% were
identified by a single peptide, and 40% were observed in
only one of the simulated iTRAQ experiments. As in the
first set of single experiment cases, no treatment-depend-
ent modifications were included.
Simulated data from the two sets of four single-experi-
ment studies and the multi-experiment study were proc-
essed with both iQuantitator and an R script that mimics
the log-space averaging approach used in the ABI soft-
ware. The log space averaging script computes raw ratios
to a selected reference and normalizes the ratios to a com-
mon median. The normalized and log-transformed ratios
for a given protein are averaged and then exponentiated to
obtain the protein-level fold change estimates. Since each
of the single experiment cases included two samples from
both control and treatment groups, our log-space averag-
ing function also computes averages of paired ratios to
give a single estimate of the fold change. Point estimates
for the protein expression fold change were taken from
each approach and compared to the true expression ratio
(recorded by the simulation).
Biological Sample Preparation and Processing
In addition to the simulated cases, we applied iQuantita-
tor to a biological sample collected as part of an on-going
study of embryonic heart development in chickens. Fertile
chicken eggs (Hubbard ISA Hatchery, Statesville, NC)
were incubated at 37°C in a humidified atmosphere with
hourly rotation for 10 to 14 days and staged according to
the criteria of Hamburger and Hamilton (HH) (1951).
Hearts from HH stage 36 (n = 72) and HH stage 39 (n =
24) were perfused in situ with warm phosphate buffered
saline, excised from the embryo and cut in half, then rinse
blotted dry, flash frozen in liquid nitrogen. Pooled hearts
from the two stages were cryo-pulverized (Bio-Pulverizer,
RPI Corp.), then homogenized in 5 mM bicine, pH 9.3
using a ground glass mortar and pestle (1:10; w:v), and
centrifuged at 700 × g for 10 min at 4°C. The cytosolic
fraction was obtained by centrifugation of the low-speed
supernatant at 150,000 × g for 90 min at 4°C (Beckman
Coulter TLX ultracentrifuge, TLS-55 rotor, 50 k rpm).
Experiments were conducted in compliance with guide-
lines established by the Institutional Animal Care and Use
Table 1: Summary of simulated data sets produced as described in the text and results of analysis using both iQuantitator and log-
space averaging.
iQuantitator Mean of 116/117 and 114/115
Simulate
d Data 
Set
Proteins Peptides Spectra Peptides 
per 
Protein
Single 
Hit 
Proteins
Mean
Error
Mean SE Median
SE
Mean
Error
Mean SE Median
SE
Case 1 1034 4776 6938 4.6 494 -0.004 0.009 0.004 0.043 0.012 0.006
Case 2 1049 4452 6359 4.2 530 0.002 0.009 0.004 -0.020 0.010 0.005
Case 3 1061 4958 7049 4.7 514 0.006 0.010 0.004 0.004 0.011 0.005
Case 4 1032 4791 6923 4.6 492 0.005 0.008 0.003 -0.004 0.009 0.004
Average 0.009 0.004 0.011 0.005
With 
Mods 1
1055 4784 6911 4.5 515 -0.002 0.037 0.011 -0.013 0.140 0.011
With 
Mods 2
1026 4744 6776 4.6 507 0.003 0.042 0.010 -0.026 0.194 0.011
With 
Mods 3
1052 4769 6830 4.5 511 0.003 0.038 0.010 -0.008 0.114 0.011
With 
Mods 4
1066 4770 6869 4.5 516 -0.001 0.042 0.010 -0.015 0.199 0.011
Average 1050 4756 6832 5 510 0.040 0.010 0.162 0.011
Multi-
Experime
nt
1321 6762 13534 5.1 620 -0.009 0.005 0.005 -0.004 0.005 0.005BMC Bioinformatics 2009, 10:342 http://www.biomedcentral.com/1471-2105/10/342
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Committee (IACUC) of the Medical University of South
Carolina for the utilization of embryonated eggs prior to
18 days of age.
One hundred micrograms of total protein (BCA reagent;
Pierce Chemical) from each aliquot were labeled with
each of the 4-Plex iTRAQ reagents (Applied Biosystems,
Foster City, CA) according to the manufacturer's standard
protocol. Briefly, the aliquots were denatured with a
sodium dodecyl sulfate solution, reduced with tris-2-car-
boxyethyl phosphine (TCEP), and alkylated by adding s-
methyl methanethiosulfonate (MMTS). The aliquots were
digested with 10 g of trypsin (Applied Biosystems) each.
Ten L of 1 M tetraethyl ammonium bicarbonate buffer
(pH 8.5) were added to ensure proper pH during labeling.
After labeling, the four aliquots were combined and frac-
tionated by strong cationic exchange (SCX) chromatogra-
phy on a Waters 600-MS HPLC system connected to a
Waters 484-MS UV detector. A PolySULFOETHYL A™ col-
umn (200 × 2.1 mm I. D., 5 m, 200 Å) (PolyLC Inc.,
Columbia, MD) was used. Solvent A was 10 mM
KH2PO4, 25% acetonitrile (ACN), pH 2.9; solvent B was
similar to A but with the addition of 1 M KCl. A 45 minute
gradient from 5% to 50% B, followed by 20 minutes at
50% B provided acceptable separation of the peptides.
The flow rate used was 250 L/minute, and the elution of
peptides was monitored by UV at 220 nm. Fractions were
collected every 5 minutes. Fractions were dried and stored
at -20°C until further use. SCX fractions containing pep-
tides were further fractionated by C18 nano-reversed
phase chromatography on an Ultimate-Switchos- Probot
system (LC Packings, Sunnyvale, CA). The peptides were
first loaded using the Switchos system on a C18 PepMap
100 pre-column (5 mm × 300 m I. D) (LC Packings)
using 2% ACN, 0.1% trifluoroacetic acid (TFA) at 40 L/
minute. After 20 minutes of desalting, the peptides were
eluted from the pre-column onto a C18 PepMap 100 col-
umn (150 mm × 75 m I. D.) (LC Packings) using the
Ultimate system at 200 nL/minute. Solvent A was 2%
ACN, 0.1% TFA; solvent B was 85% ACN, 5% 2-propanol,
and 0.1% TFA. An 80 minute gradient from 5% B to 50%
B, followed by 30 minutes at 50% B was used. Peptide elu-
tion was monitored at 214 nm. The eluant from the
reversed-phase HPLC separation was mixed at a 1:2 (elu-
ant: matrix) ratio with a solution of -cyano-4-hydroxy-
cinnamic acid (Bruker Daltonics, Billerica, MA) being
continuously delivered from the syringe pump of the Pro-
bot system. The mixture was spotted on stainless steel
MALDI plates (Applied Biosystems) in a 24 × 24 pattern.
Spots were collected every 10 seconds during peptide elu-
tion of the reversed phase chromatography run. Typically,
two plates were collected for each SCX fraction. Six mass
calibration spots were manually spotted on the perimeter
of the plate, and two mass accuracy verification spots were
manually placed on the top center and bottom center of
each plate. Matrix-assisted laser desorption ionization
mass spectrometry (MALDI-MS) analyses was performed
on a 4700 Proteomics Analyzer tandem time-of flight
(TOF) mass spectrometer (Applied Biosystems). One MS
spectrum was acquired for each spot in positive reflector
mode; subsequently the 15 most intense precursors from
each spot were selected for tandem MS/MS sequencing.
For peptides eluting in more than one spot, the interpre-
tation method was set up to minimize repetition of the
MS/MS data collection on the same precursor. MS/MS
spectra were collected starting with the least abundant
peptide in each fraction to maximize data quality. The raw
MS/MS data were filtered using a signal-to-noise ratio of
15 and searched using GPS Explorer software (version
3.6) and Mascot (version 2.1). iTRAQ labeled N-terminal
and Lysine, and MMTS labeled cysteine were selected as
fixed modifications, while oxidation of methionine and
iTRAQ labeled tyrosine were used as variable modifica-
tions. A 70% confidence cut-off was used at the peptide
level. The Gallus gallus protein database used for the
search was extracted from the NCBI non-redundant data-
base downloaded from the NCBI website on May 4, 2005.
The MS/MS summary report containing peptide sequence,
Mascot scores, protein assignment to each peptide, iTRAQ
reporter areas (corrected for isotopic impurity based on
the certified purity supplied by the manufacturer with
each batch of reagents), and other information used in
this study were generated using the GPS Explorer software.
Tandem MS summary reports comparing stage 36 and
stage 39 chicken hearts and containing 15,813 MSMS
spectra were processed using iQuantitator. Of those spec-
tra, 14,488 lacked a high confidence identification, and
42 were eliminated due to disallowed modifications
(iTRAQ-modified tyrosines) leaving 1,283 spectra with
high confidence identifications from 438 unique proteins
and 970 peptides. Using iQuantitator, 200,000 samples
were collected from the Markov chain following a burn-in
period of 40,000 updates. The samples were thinned by a
factor of 20 leaving 5,000 samples from which summary
statistics were collected. For each protein and each associ-
ated peptide, mean, median, and 95% credible intervals
were computed for each of the protein- and peptide-level
treatment effects.
Results
Simulated Data
We find that the model-based approach implemented
here results in a smaller mean square error in the esti-
mated log fold changes (see Table 1) when compared to
individual paired estimates using the log averaging
approach or when those paired estimates are averaged.
This is especially evident in the second set of cases (simu-
lated modifications) where the log-space mean square
error was found to be 0.04 using iQuantitator and 0.19BMC Bioinformatics 2009, 10:342 http://www.biomedcentral.com/1471-2105/10/342
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using the log averaging approach. In these cases, a number
of peptides exhibit fold changes that differ greatly from
the associated protein when only one form of that peptide
is observed (modified or unmodified) and the extent of
modification varies across samples or treatment groups.
The histograms of Figure 5 give error distributions for the
two approaches and illustrate the presence of the few cases
that greatly increase the mean error in the log-space aver-
aging approach. When the median square error is used
instead of the mean square error, the few cases resulting in
large errors are less important and the difference between
iQuantitator and the log-averaging approach is less noti-
cable (0.01 vs 0.02). Many proteins identified in iTRAQ
experiments are associated with only a few peptides.
Using the log-space averaging approach, the fold change
estimate for a protein makes no use of the data associated
with other proteins/peptides and the overall distribution
of fold changes seen in the data. The inclusion of a com-
mon prior distribution allows information to be shared
across proteins and combines data across samples. In
these examples, two samples from each treatment group
were included in the experiment. Here, we used the model
to combine information from samples from each treat-
ment group to create a single estimate of the expression
change across groups. In the simulated multi-experiment
case, the results from iQuantitator and the log-space aver-
Histograms showing errors in the log fold change estimate for a representative case without modifications (panels A and B) and  a representative case with modifications (panels C and D) for iQuantitator (panels A and C) and the log-space averaging  approach (panels B and D) provide a comparison of these methods Figure 5
Histograms showing errors in the log fold change estimate for a representative case without modifications 
(panels A and B) and a representative case with modifications (panels C and D) for iQuantitator (panels A and 
C) and the log-space averaging approach (panels B and D) provide a comparison of these methods. Inset graphs 
show the complete histogram for each case and main plots limit the y axis to 20 to make the proteins with larger errors more 
visible. Without modifications, both methods give similar results, with modifications the mean square error for iQuantitator is 
noticeably lower due to a relatively few proteins with large fold change errors in the log space averaging approach.BMC Bioinformatics 2009, 10:342 http://www.biomedcentral.com/1471-2105/10/342
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aging approach were comparable. As in the first group of
single-experiment cases, no treatment dependent modifi-
cations were included and, as before, the mean square
errors for the two methods were similar (Table 1).
While the proposed method demonstrates a lower predic-
tion error, we must also note that the method tends to
produce estimates shifted towards the null hypothesis (no
change in expression). Resulting estimates are, thus, con-
servative. In the model used in this study, the prior distri-
bution is given a 0 mean with an unknown precision, thus
indicating a prior preference for the null hypothesis. The
prior specification can be adjusted to relax this preference
as desired. We also note that in cases where the data is
noisy and the resulting estimates in precision are small,
the shift tends to increase. This effect is evident in Equa-
tion (2) which gives the rule for updating the model
effects. The update mean is a sum of the prior mean and
the mean estimated from the data, weighted by the prior
precision and the model precision. With noisy data, the
prior precision can tend to dominate, driving the estimate
toward the prior mean (0 in this case) and thus underesti-
mating the magnitude of the expression change. We find
that with proper selection of prior parameters, the disad-
vantage of the null shift tends to be balanced by the
improved accuracy in the expression change estimate.
Adjustment of the prior specification can be used to con-
trol this balance.
Chicken Heart Development
Embryonic development is an excellent model system for
evaluating a continuum of protein expression dynamics as
no extrinsic manipulations are required to affect change -
it is a highly integrated melody of natural processes,
which minimizes experimenter-related error. While early
embryonic events proceed rapidly, the later phases of
development are largely characterized by overt growth of
organs and tissues that approximate their more mature
counter parts Martinsen (2005). We chose to compare the
chick heart cytosol proteome of HH stage 36 vs 39
embryos as this time difference coincides primarily with a
3-4 fold increase in muscle mass. There are also more sub-
tle, but critical changes in the conduction system and val-
vular structure, with the potential for detecting tissue
specific isoform expression that would allow for assessing
the detection limits of the iTRAQ methodology. However,
the results of the HH stage 36 vs. 39 comparison showed
little difference in the heart cytosolic protein composition
aside from constituents in the blood, possibly reflecting
expansion of the coronary network.
To facilitate further understanding of the performance of
the software described here, we also compared estimates
derived using log space averaging to the estimates pro-
vided by iQuantitator. In this experiment, two samples
from each of two treatment groups were processed, ratios
for each of the two control treatment pairs were computed
for each reported spectrum with identification meeting
the search criteria (see Methods). Each set of ratios was
normalized to the median of the set. For each protein the
log-space average of the normalized ratios for all spectra
assigned to a given protein is computed providing a single
log-ratio average for each identified protein. Figure 6 com-
pares the estimates provided by the two methods. From
the figure we see the tendency toward conservative esti-
mates when using iQuantitator discussed above. While
proteins identified by a single peptide would not nor-
mally be reported, we plot them here (open circles) to
illustrate how the shift toward more conservative esti-
mates is affected by the available information.
Discussion
We report here on the development and application of a
new software tool, iQuantitator, designed to facilitate
analysis and reporting of iTRAQ data. The tool's model-
based approach, inference using the Bayesian framework,
customized Gibbs Sampler, and R-based hypertext-linked
report generator aid in the analysis of iTRAQ data for a
variety of experimental designs.
Experiments involving multiple iTRAQ runs present a
number of challenges including limited coverage overlap
across runs, proteins identified by single peptides, and
Comparison of expression change estimates using iQuantita- tor and log-space averages for data from stage HH36 versus  HH39 embryonic chicken hearts Figure 6
Comparison of expression change estimates using 
iQuantitator and log-space averages for data from 
stage HH36 versus HH39 embryonic chicken hearts. 
Solid circles give results for proteins identified by more than 
one peptide, open circles give results for proteins identified 
by a single peptide. Dotted lines give a linear fit in log coordi-
nates and illustrate tendency toward conservative estimates 
of fold change.BMC Bioinformatics 2009, 10:342 http://www.biomedcentral.com/1471-2105/10/342
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proteins appearing in a single experiment. The statistical
and computational approach employed here attempts to
address many of these problems without requiring special
handling. As noted above, the approach used here allows
for information sharing across levels of a given model
effect (termed a "batch"). For example, the treatment-
dependent protein relative expression estimate is based
on both the information specific to that protein and the
variation in relative expression over all proteins. This shar-
ing of information is evident in Equation (2), the update
rule for model parameters. Within the model, the term
gj(i), c represents the log difference between protein i's treat-
ment-dependent change in expression and that of associ-
ated peptide j(i). When a single peptide identifies a
protein, the relative expression estimate is shared between
gj(i), c and ri, c. When peptides within the sample provide
consistent estimates of the associated protein, the protein-
level estimate for proteins identified by a single peptide
tend to follow the peptide estimate and the posterior esti-
mate of gj(i), c tends toward 0. In cases where the peptide-
level estimates of relative expression differ significantly
from the associated protein-level estimates, as in our sim-
ulated cases involving protein modifications, the tend-
ancy is for a more pronounced shift toward conservative
estimates of relative expression. Difference in estimates
for proteins identified by a single peptide and those iden-
tified by more than one peptide can be seen in Figure 6
where we see an increased tendency for estimates to shift
toward the null hypothesis (more conservative estimate).
In cases of increased noise or limited data, the software
tends to produce more conservative estimates.
High-throughput proteomics is a complicated process
involving chemical modification, instrumentation, and
information processing. An objective of this effort has
been the development of an approach that links the bio-
logical parameters of interest (protein expression levels)
to the observed quantities (reporter ion peak areas)
through a model that represents the sources of variation in
the experimental process. The development of a model-
based inference approach eases the adaptation of the soft-
ware to changing experimental designs and processes.
iQuantitator employs statistically-motivated inference for
parameters of a model derived from the experimental
process. As such, the sources of variation accounted for in
the model are evident and the exponentiated value of each
parameter has a clear meaning. The model includes both
protein and peptide-level treatment effect estimates allow-
ing for the identification of proteins whose expression
changes in a treatment-dependent manner as well as for
peptides differentially expressed (modifications, splice
variants) relative to the associated proteins. The model
can be adapted to a variety of experimental designs, can
accommodate more than one treatment group, is not
restricted to a single reference channel, and can merge
information across experiments.
While a variety of web-based tools have been developed,
we choose to consider presentation of results using an
electronic document (e-Document) based on the Portable
Document Format. Hypertext linking both within the
document and to web resources provides many of the fea-
tures of a web-based interface in a single file that can be
easily distributed and viewed with a variety of document
readers. The document structure chosen here allows the
user to drill down from protein-level data with graphically
depicted expression changes and associated uncertainty to
the supporting peptide data with summaries across multi-
ple iTRAQ experiments. The entire document is book-
marked and searchable using the capabilities of the user's
PDF reader. We believe that many additional features
could be included in the e-document report through the
use of embedded scripting (Javascript) and forms. Addi-
tionally, the design of the package allows other reporting
interfaces to be incorporated. The Sweave package used
here can also generate HTML using a similar approach and
existing interfaces between R and common database
engines allow the possibility of pushing results directly to
a data management system.
Conclusion
Rapid advances in high-throughput proteomic technolo-
gies are requiring comparable advances in modeling, sta-
tistical methods, and visualization. iQuantitator's
process-based modeling approach overcomes limitations
in current methods and allows for application in a variety
of experimental designs and meaningful integration of
data across experiments. Additionally, inference in the
Bayesian framework and an efficient Gibbs Sampler over-
comes estimation problems noted by other researchers.
iQuantitator is available from the authors as an installable
R package.
Availability and Requirements
Project name: iQuantitator
Operating system(s): Platform independent
Programming language: R, C
Other requirements: The R software for statistical comput-
ing (version 2.6.2 or later), pdflatex (for hypertext-linked
report generation)
License: GNU GPL
Any restrictions to use by non-academics: NoneBMC Bioinformatics 2009, 10:342 http://www.biomedcentral.com/1471-2105/10/342
Page 14 of 15
(page number not for citation purposes)
An installable R package including all source code [see
Additional File 1], sample output [see Additional File 2],
a document describing the installation and application of
the software [see Additional File 3], an input file contain-
ing the MSMS summary reports from our experiment [see
Additional File 4], a sample R script demonstrating the
analysis of experimental data described here [see Addi-
tional File 5], and a test-case specific protein sequence file
in FASTA format [see Additional File 6] are provided.
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